Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 320 participants.

Also called NCT07768631

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 320 participants (planned count) (from the registry)
Sponsor
Endogenex, Inc. (from the registry)
Registry
  • NCT NCT07768631
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07768631. Randomized; double masking; primary purpose treatment. Start 2027-01-01 (anticipated); primary completion 2029-11-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes
Acronym
pulsENDO
Condition
Diabetes Type 2
Condition
Diabetes
Condition
Diabetes (DM)
Condition
Weight Change
Condition
Glycemic Control
Condition
Glycemic Control for Diabetes Mellitus
Intervention (Device)
pulsENDO Therapy
Lead sponsor
Endogenex, Inc. (class: industry)

Record details

Record id
cardio:ct-nct07768631
Content hash
d9a075e1a7e476d98c70f2df65c5a769e19ba553ca0f68f330ae88e66d520a73